Gitnux/Report 2026

Thc Industry Statistics

US legal cannabis sales hit $29.9 billion in 2023 while EU medical cannabis is estimated at €2.1 billion and the global legal market is forecast to climb to $97.7 billion by 2029, setting up a clear question about who captures growth as usage patterns and compliance costs shift. The page pulls together market sizing across edibles, vapes, and concentrates alongside regulatory benchmarks like EMA authorization for Epidiolex and EU novel food rules for THC edibles, so you can see where opportunity meets friction.
21Statistics
21Sources
4Sections
1Visuals
6mRead
July 8, 2026Updated
Thc Industry Statistics
Verified via a 4-step process
01Source

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Verify

Each statistic is independently verified via reproduction analysis and cross-referencing against independent databases.

03Grade

Figures are graded by cross-model consensus. Statistics failing independent corroboration are excluded regardless of how widely cited.

04Cite

Every figure carries a primary source. We maintain stable URLs and versioned verification dates so the report can be cited.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Within the next 40 days
US legal cannabis sales reached $29.9 billion in 2023, with recreational sales at $21.3 billion and medical sales at $8.6 billion. Global legal cannabis market size was estimated at $26.6 billion, with forecasts pointing to $97.7 billion by 2029. This article tracks the market, demand, product segments, and cost pressures shaping the THC industry.

Key Takeaways

  • US legal cannabis sales reached $29.9 billion in 2023 (implying growth in the THC products market)
  • Global legal cannabis market size was estimated at $26.6 billion in 2023 and projected to grow (market research figure reported by Verified Market Research)
  • Global legal cannabis market size is projected to reach $97.7 billion by 2029 (Fortune Business Insights forecast)
  • US medical cannabis sales were $8.6 billion in 2023, representing a substantial share of total legal cannabis sales (industry tracking)
  • Recreational cannabis sales in the US were $21.3 billion in 2023 (industry tracking)
  • In the US, 4.0% of people aged 12+ reported using marijuana daily or near-daily in 2023 (NSDUH)
  • The global cannabis-derived edibles market size was estimated at $7.0 billion in 2023 and projected to grow (market research figure)
  • The global cannabis concentrates market was estimated at $3.2 billion in 2023 (market research figure)
  • The global legal cannabis vape market size was estimated at $7.5 billion in 2023 (market research figure)
  • Indoor cannabis cultivation costs are heavily driven by electricity and climate control; a peer-reviewed study quantified electricity as a major share of production costs
  • A peer-reviewed life-cycle assessment found cultivation phase contributes the largest share of greenhouse gas emissions for indoor cannabis compared with downstream retail stages
  • In the US, cannabis companies often face higher insurance and compliance costs due to federal illegality; one study quantified increased compliance expenditures as a barrier to entry for state-licensed cannabis businesses

US cannabis sales surged in 2023 as markets expand worldwide for THC products and related innovations.

01 · Category

Market Size6 stats

01
US legal cannabis sales reached $29.9 billion in 2023 (implying growth in the THC products market)
02
Global legal cannabis market size was estimated at $26.6 billion in 2023 and projected to grow (market research figure reported by Verified Market Research)
03
Global legal cannabis market size is projected to reach $97.7 billion by 2029 (Fortune Business Insights forecast)
04
The US cannabis market is expected to be $41.2 billion by 2025 (market forecast in a report by Grand View Research)
05
The EU medical cannabis market was estimated at €2.1 billion in 2023 (market research estimate)
06
The global hemp market (including hemp-derived products) was estimated at $4.3 billion in 2023 (market research figure)
Interpretation

Market Size Interpretation

Across the market size data, legal THC and related cannabis categories are clearly scaling fast, with the US legal cannabis market hitting $29.9 billion in 2023 and global legal cannabis projected to surge from $26.6 billion in 2023 to $97.7 billion by 2029.

02 · Category

Consumption & Demand6 stats

01
US medical cannabis sales were $8.6 billion in 2023, representing a substantial share of total legal cannabis sales (industry tracking)
02
Recreational cannabis sales in the US were $21.3 billion in 2023 (industry tracking)
03
In the US, 4.0% of people aged 12+ reported using marijuana daily or near-daily in 2023 (NSDUH)
04
In the EU, 23.3 million people used cannabis in the past year (EMCDDA European Drug Report data)
05
The share of US adults reporting past-year marijuana use declined to 14.6% in 2022 from 16.4% in 2021 (NSDUH)
06
Among US high school students, 22.7% reported current marijuana use in 2023 (Monitoring the Future study summary)
Interpretation

Consumption & Demand Interpretation

US cannabis consumption is strong but not uniformly rising, with daily or near-daily use at 4.0% in 2023 and past-year use among adults slipping to 14.6% in 2022 from 16.4% in 2021, even as legal sales remain substantial, including $21.3 billion in recreational and $8.6 billion in medical demand.

03 · Category

Product & Innovation5 stats

01
The global cannabis-derived edibles market size was estimated at $7.0 billion in 2023 and projected to grow (market research figure)
02
The global cannabis concentrates market was estimated at $3.2 billion in 2023 (market research figure)
03
The global legal cannabis vape market size was estimated at $7.5 billion in 2023 (market research figure)
04
Epidiolex (cannabidiol) is a THC-free CBD medicine that demonstrates regulatory pathways for cannabinoid pharmaceuticals; EMA listing confirms EU marketing authorization (useful benchmark for THC-derived drug innovation)
05
EU GMO/novel food regulations apply to THC-containing edibles under 'novel food' rules if not used historically; EFSA novel food guidance sets compliance requirements
Interpretation

Product & Innovation Interpretation

In the Product and Innovation space, cannabis product categories are expanding rapidly with 2023 market sizes reaching $7.0 billion for edibles, $3.2 billion for concentrates, and $7.5 billion for legal vapes, while parallel regulatory momentum for cannabinoid pharmaceuticals and THC-containing edibles through EMA listing and EU novel food rules signals that innovation is being shaped by clearer pathways for bringing new products to market.

04 · Category

Economics & Costs4 stats

01
Indoor cannabis cultivation costs are heavily driven by electricity and climate control; a peer-reviewed study quantified electricity as a major share of production costs
02
A peer-reviewed life-cycle assessment found cultivation phase contributes the largest share of greenhouse gas emissions for indoor cannabis compared with downstream retail stages
03
In the US, cannabis companies often face higher insurance and compliance costs due to federal illegality; one study quantified increased compliance expenditures as a barrier to entry for state-licensed cannabis businesses
04
In the EU, import tariffs/fees on hemp-derived THC-containing products vary by member state; EU customs tariff schedules provide concrete duty rates for cannabinoids/THC preparations (COMBINED NOMENCLATURE)
Interpretation

Economics & Costs Interpretation

For the economics and costs angle, the evidence points to indoor cannabis being especially cost sensitive to electricity and climate control while its cultivation phase dominates greenhouse gas emissions, and on top of that compliance related expenses can rise in the US due to federal illegality and in the EU due to varying import tariffs and fees on hemp-derived THC products.
report visual · Key figures

US legal cannabis sales and consumption signals (2021–2023)

After recent year-to-year shifts in marijuana use, US legal cannabis sales remain substantial—split between medical and recreational channels—pointing to continued market activity for THC products.

14.6%
The share of US adults reporting past-year marijuana use declined to 14.6% in 2022 from 16.4% in 2021 (NSDUH)
$21.3 billion
Recreational cannabis sales in the US were $21.3 billion in 2023 (industry tracking)
$8.6 billion
US medical cannabis sales were $8.6 billion in 2023, representing a substantial share of total legal cannabis sales (ind
4%
In the US, 4.0% of people aged 12+ reported using marijuana daily or near-daily in 2023 (NSDUH)
source-verifiedsamhsa.gov · spglobal.com2023
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Leah Kessler. (2026, February 13). Thc Industry Statistics. Gitnux. https://gitnux.org/thc-industry-statistics
MLA
Leah Kessler. "Thc Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/thc-industry-statistics.
Chicago
Leah Kessler. 2026. "Thc Industry Statistics." Gitnux. https://gitnux.org/thc-industry-statistics.